semaglutide updates Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous 7.2 mg for obesity Vitality Medical | Big update

Proper dose titration and injection technique minimize most side effects

Hardy TJ

Current clinical trials of next-generation drugs indicate that some treatments possess excellent potential to overcome the MDR issue

Key Research Characteristics: Extended half-life (~2030 hours vs ~1215 minutes for native IGF-1) due to reduced IGFBP binding Potent agonist at IGF-1R, studied for roles in cellular proliferation, differentiation, and survival signalling Investigated in models of muscle hypertrophy, neuroprotection, and metabolic regulation 83 amino acid analogue

Henceforth, the right dosage should be taken into consideration

Thiol-reduced glutathione (GSH) synthesis GSH is made available in cells through 3 processes, summarized in Figure 1